Phase II study of interferon-alpha (IFN), Gleevec or Iressa patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Amato, R [1 ]
Kareidy, M [1 ]
Marsh, L [1 ]
Truong, L [1 ]
Shen, S [1 ]
机构：
[1] Methodist Hosp, Res Inst, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9030S / 9030S
页数：1
相关论文
共 50 条
  • [21] Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
    Niwakawa, Masashi
    Hashine, Katsuyoshi
    Yamaguchi, Raizo
    Fujii, Hirofumi
    Hamamoto, Yasuo
    Fukino, Koichi
    Tanigawa, Takahiko
    Sumiyoshi, Yoshiteru
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1046 - 1054
  • [22] Use of STAT3 polymorphisms to predict overall survival in patients treated with interferon-alpha for metastatic renal cell carcinoma.
    Eto, Masatoshi
    Kamba, Tomomi
    Miyake, Hideaki
    Fujisawa, Masato
    Kamai, Takao
    Uemura, Hirotsugu
    Tsukamoto, Taiji
    Azuma, Haruhito
    Matsubara, Akio
    Nishimura, Kazuo
    Nakamura, Tsuyoshi
    Ogawa, Osamu
    Naito, Seiji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
    Kankuri-tammilehto, Minna
    Perasto, Laura
    Pyrhonen, Seppo
    Salminen, Eeva
    [J]. ANTICANCER RESEARCH, 2023, 43 (06) : 2645 - 2657
  • [24] Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma
    Clark, PE
    Hall, MC
    Miller, A
    Ridenhour, KP
    Stindt, D
    Lovato, JF
    Patton, SE
    Brinkley, W
    Das, S
    Torti, FM
    [J]. UROLOGY, 2004, 63 (06) : 1061 - 1065
  • [25] Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma
    Lummen, G
    Goepel, M
    Mollhoff, S
    Hinke, A
    Otto, T
    Rubben, H
    [J]. JOURNAL OF UROLOGY, 1996, 155 (02): : 455 - 458
  • [26] RECOMBINANT INTERFERON-ALPHA WITH OR WITHOUT VINBLASTINE IN METASTATIC RENAL-CARCINOMA - RESULTS OF A RANDOMIZED PHASE-II STUDY
    FOSSA, SD
    RAABE, N
    MOE, B
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 64 (05): : 468 - 471
  • [27] Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
    Ellerhorst, JA
    Sella, A
    Amato, RJ
    Tu, SM
    Millikan, RE
    Finn, LD
    Banks, M
    Logothetis, CJ
    [J]. CANCER, 1997, 80 (11) : 2128 - 2132
  • [28] RECOMBINANT ALPHA INTERFERON IN METASTATIC RENAL-CELL CARCINOMA - A COOPERATIVE PHASE-II STUDY
    BONO, AV
    BRAUSI, M
    REALI, L
    VICINI, D
    BENVENUTI, C
    PAVONEMACALUSO, M
    RIGATTI, P
    ANSELMO, G
    GIBBA, A
    COPPI, F
    COSCIANICUNICO, S
    FRANCH, L
    [J]. UROLOGY, 1991, 38 (01) : 60 - 63
  • [29] Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
    Rini, B. I.
    Halabi, S.
    Rosenberg, J.
    Stadler, W. M.
    Vaena, D. A.
    Atkins, J. N.
    Picus, J.
    Czaykowski, P.
    Dutcher, J.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
    Masashi Niwakawa
    Katsuyoshi Hashine
    Raizo Yamaguchi
    Hirofumi Fujii
    Yasuo Hamamoto
    Koichi Fukino
    Takahiko Tanigawa
    Yoshiteru Sumiyoshi
    [J]. Investigational New Drugs, 2012, 30 (3) : 1274 - 1275
12345